Dendrimer-based drug delivery systems: History, challenges, and latest developments

J Wang, B Li, L Qiu, X Qiao, H Yang - Journal of biological engineering, 2022‏ - Springer
Since the first dendrimer was reported in 1978 by Fritz Vögtle, dendrimer research has
grown exponentially, from synthesis to application in the past four decades. The distinct …

Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics

KR Gajbhiye, R Salve, M Narwade, A Sheikh… - Molecular Cancer, 2023‏ - Springer
Lipid-based polymeric nanoparticles are the highly popular carrier systems for cancer drug
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …

Emerging trends of nanotechnology in advanced cosmetics

SK Dubey, A Dey, G Singhvi, MM Pandey… - Colloids and surfaces B …, 2022‏ - Elsevier
The cosmetic industry is dynamic and ever-evolving. Especially with the introduction and
incorporation of nanotechnology-based approaches into cosmetics for evincing novel …

Clusterization-triggered emission: Uncommon luminescence from common materials

H Zhang, Z Zhao, PR McGonigal, R Ye, S Liu… - Materials Today, 2020‏ - Elsevier
Abstract π-Conjugated chromophores have been investigated for many years and
successful theoretical models have been developed to explain their photophysical …

Structure‐based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles

R De, MK Mahata, KT Kim - Advanced Science, 2022‏ - Wiley Online Library
Carriers are equally important as drugs. They can substantially improve bioavailability of
cargos and safeguard healthy cells from toxic effects of certain therapeutics. Recently …

[HTML][HTML] Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy

L Palmerston Mendes, J Pan, VP Torchilin - Molecules, 2017‏ - mdpi.com
Dendrimers are highly branched polymers with easily modifiable surfaces. This makes them
promising structures for functionalization and also for conjugation with drugs and DNA/RNA …

PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy

F Abedi-Gaballu, G Dehghan, M Ghaffari, R Yekta… - Applied materials …, 2018‏ - Elsevier
Drug delivery systems for cancer chemotherapy are employed to improve the effectiveness
and decrease the side-effects of highly toxic drugs. Most chemotherapy agents have …

Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy

S Mukherjee, S Mukherjee, MAS Abourehab… - European Polymer …, 2022‏ - Elsevier
Cancer immunotherapy has been researched as a major modality of treatment which
involves activating the immune system of the patient to fight against tumor cells. Dendrimers …

CD44-targeted nanocarrier for cancer therapy

P Kesharwani, R Chadar, A Sheikh, WY Rizg… - Frontiers in …, 2022‏ - frontiersin.org
Cluster of differentiation 44 (CD44) is a cell surface glycoprotein overexpressed in varieties
of solid tumors including pancreatic, breast, ovary, brain, and lung cancers. It is a multi …

Research status of dendrimer micelles in tumor therapy for drug delivery

X Wang, M Zhang, Y Li, H Cong, B Yu, Y Shen - Small, 2023‏ - Wiley Online Library
Dendrimers are a family of polymers with highly branched structure, well‐defined
composition, and extensive functional groups, which have attracted great attention in …